Title
Evisceration and Sympathetic Ophthalmia: Is there a risk?,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Sympathetic Ophthalmia (SO) is a rare, but devastating eye condition that occurs bilaterally ? usually 48 weeks after a traumatic event. It is perceived that the risk of SO is eliminated if the injured eye is removed as a primary procedure; and decreased if secondary removal is performed. It is also thought to be safer to remove the eye by enucleation (removal of the entire globe) rather than by evisceration (removal of the globe contents only). Evisceration does, however, have definite advantages over enucleation, including being a technically simpler surgical procedure. Evisceration may become the preferred and accepted procedure for removal of the globe following trauma if it can be conclusively shown that the risk of SO after evisceration is negligible and less than the 0.19% (range 0.1 ? 0.3%) quoted in the literature. Many cases of penetrating ocular trauma are seen at Groote Schuur Hospital (GSH) every year ? more than at other centres in the world. By analyzing our data over a 10year period, we hoped to demonstrate that the risk of SO is minimal or nonexistent following evisceration for ocular trauma.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.